Rituximab useful for providing relief to membranous nephropathy patients
Membranous nephropathy, which is a disorder of the kidneys, could be effectively treated with Rituximab.
According to findings appearing in the April 2009 print issue of the Clinical Journal of the American Society of Nephrology (CJASN), this drug could help patients by offering dramatic relief to them.
From News-Medical.Net:
To investigate rituximab’s potential, Andrew Bomback, MD (University of North Carolina Kidney Center), and his colleagues conducted the first systematic review of rituximab use in patients with membranous nephropathy. They collected and analyzed all of the data available on rituximab therapy in this patient population. They found 21 articles to date, all of which were either case reports or case series without controls, meaning that patients taking rituximab were studied for a certain length of time but were not compared with patients not taking the drug.
Comparisons were made between rituximab therapy with nephropathy by Andrew Bomback, M.D., University of North Carolina Kidney Center and his colleagues and rituximab proved to be a better choice. Till now, treatment options for the disorder were limited to steroids, calcineurin inhibitors, and chemotherapeutic agents, all of which have side effects.
